Your browser doesn't support javascript.
Installing oncofertility programs for common cancers in limited resource settings (Repro-Can-OPEN Study): An extrapolation during the global crisis of Coronavirus (COVID-19) pandemic.
Salama, M; Ataman-Millhouse, L; Braham, M; Berjeb, K; Khrouf, M; Rodrigues, J K; Reis, F M; Silva, T Cury-; Sánchez, F; Romero, S; Smitz, J; Vásquez, L; Vega, M; Sobral, F; Terrado, G; Lombardi, M G; Scarella, A; Bourlon, M T; Verduzco-Aguirre, H; Sánchez, A M; Adiga, S K; Tholeti, P; Udupa, K S; Mahajan, N; Patil, M; Dalvi, R; Venter, C; Demetriou, G; Geel, J; Quintana, R; Rodriguez, G; Quintana, T; Viale, L; Fraguglia, M; Coirini, M; Remolina-Bonilla, Y A; Noguera, J A R; Velásquez, J C; Suarez, A; Arango, G D; Pineda, J I D; Aldecoa, M D C; Javed, M; Al Sufyan, H; Daniels, N; Oranye, B C; Ogunmokun, A A; Onwuzurigbo, K I; Okereke, C J; Whesu, T C.
  • Salama M; Oncofertility Consortium, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. eaims_gm@yahoo.com.
  • Ataman-Millhouse L; Oncofertility Consortium, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Braham M; Aziza Othmana Hospital of Tunis, Tunis, Tunisia.
  • Berjeb K; Aziza Othmana Hospital of Tunis, Tunis, Tunisia.
  • Khrouf M; FERTILLA, Clinique la Rose, Tunis, Tunisia.
  • Rodrigues JK; Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Reis FM; Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Silva TC; Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Sánchez F; Laboratorio de Biología Reproductiva y Preservación de la Fertilidad, Laboratorios de Investigación y Desarrollo, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Romero S; Laboratorio de Biología Reproductiva y Preservación de la Fertilidad, Laboratorios de Investigación y Desarrollo, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Smitz J; Laboratorio de Biología Reproductiva y Preservación de la Fertilidad, Laboratorios de Investigación y Desarrollo, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Vásquez L; Unidad de Oncología Pediátrica, Hospital Edgardo Rebagliati Martins, Lima, Peru.
  • Vega M; Panama Fertility, Sistema Nacional de Investigadores, Panama City, Panama.
  • Sobral F; Pregna Medicina Reproductiva, Buenos Aires, Argentina.
  • Terrado G; Pregna Medicina Reproductiva, Buenos Aires, Argentina.
  • Lombardi MG; Pregna Medicina Reproductiva, Buenos Aires, Argentina.
  • Scarella A; Centro de Reproduccion Humana, Facultad de Medicina, Universidad de Valparaiso, Valparaiso, Chile.
  • Bourlon MT; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Verduzco-Aguirre H; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Sánchez AM; Instituto Nacional de Perinatología Isidro Espinoza de los Reyes, Mexico City, Mexico.
  • Adiga SK; Fertility Preservation Centre, Department of Clinical Embryology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
  • Tholeti P; Fertility Preservation Centre, Department of Clinical Embryology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
  • Udupa KS; Department of Medical Oncology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
  • Mahajan N; Mother and Child Hospital, New Delhi, India.
  • Patil M; Dr. Patil's Fertility and Endoscopy Clinic, Bangalore, India.
  • Dalvi R; Hospital Institute of Medical Sciences & SRCC children's Hospital, Mumbai, India.
  • Venter C; Vitalab Fertility Centre, Johannesburg, South Africa.
  • Demetriou G; Department Medical Oncology, University of Witwatersrand, Johannesburg, South Africa.
  • Geel J; Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
  • Quintana R; Procrearte, Buenos Aires, Argentina.
  • Rodriguez G; Procrearte, Buenos Aires, Argentina.
  • Quintana T; Procrearte, Buenos Aires, Argentina.
  • Viale L; Procrearte, Buenos Aires, Argentina.
  • Fraguglia M; Procrearte, Buenos Aires, Argentina.
  • Coirini M; Hospital de Niños Victor J. Vilela. Rosario, Santa Fe, Argentina.
  • Remolina-Bonilla YA; Instituto Nacional de Cancerología, Bogota, Colombia.
  • Noguera JAR; Instituto Nacional de Cancerología, Bogota, Colombia.
  • Velásquez JC; Instituto Nacional de Cancerología, Bogota, Colombia.
  • Suarez A; Instituto Nacional de Cancerología, Bogota, Colombia.
  • Arango GD; FERTIVIDA Fertility Center, Bogota, Colombia.
  • Pineda JID; Instituto Guatemalteco de Seguridad Social (IGSS), Guatemala City, Guatemala.
  • Aldecoa MDC; Instituto Guatemalteco de Seguridad Social (IGSS), Guatemala City, Guatemala.
  • Javed M; Thuriah Medical Center, Riyadh, Kingdom of Saudi Arabia.
  • Al Sufyan H; Thuriah Medical Center, Riyadh, Kingdom of Saudi Arabia.
  • Daniels N; The Oncology and Fertility Centres of Ekocorp Plc, Eko Hospitals, Lagos, Nigeria.
  • Oranye BC; The Oncology and Fertility Centres of Ekocorp Plc, Eko Hospitals, Lagos, Nigeria.
  • Ogunmokun AA; The Oncology and Fertility Centres of Ekocorp Plc, Eko Hospitals, Lagos, Nigeria.
  • Onwuzurigbo KI; Kingswill Specialist Hospital, Lagos, Nigeria.
  • Okereke CJ; Kingswill Specialist Hospital, Lagos, Nigeria.
  • Whesu TC; Kingswill Specialist Hospital, Lagos, Nigeria.
J Assist Reprod Genet ; 37(7): 1567-1577, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: covidwho-617321
ABSTRACT

PURPOSE:

The state of limited resource settings that Coronavirus (COVID-19) pandemic has created globally should be taken seriously into account especially in healthcare sector. In oncofertility, patients should receive their fertility preservation treatments urgently even in limited resource settings before initiation of anticancer therapy. Therefore, it is very crucial to learn more about oncofertility practice in limited resource settings such as in developing countries that suffer often from shortage of healthcare services provided to young patients with cancer.

METHODS:

As an extrapolation during the global crisis of COVID-19 pandemic, we surveyed oncofertility centers from 14 developing countries (Egypt, Tunisia, Brazil, Peru, Panama, Mexico, Colombia, Guatemala, Argentina, Chile, Nigeria, South Africa, Saudi Arabia, and India). Survey questionnaire included questions on the availability and degree of utilization of fertility preservation options in case of childhood cancer, breast cancer, and blood cancer.

RESULTS:

All surveyed centers responded to all questions. Responses and their calculated oncofertility scores showed different domestic standards for oncofertility practice in case of childhood cancer, breast cancer, and blood cancer in the developing countries under limited resource settings.

CONCLUSIONS:

Medical practice in limited resource settings has become a critical topic especially after the global crisis of COVID-19 pandemic. Understanding the resources necessary to provide oncofertility treatments is important until the current COVID-19 pandemic resolves. Lessons learned will be valuable to future potential worldwide disruptions due to infectious diseases or other global crises.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Atención a la Salud / Pandemias / Preservación de la Fertilidad / Betacoronavirus / Neoplasias Tipo de estudio: Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Límite: Femenino / Humanos Idioma: Inglés Revista: J Assist Reprod Genet Asunto de la revista: Genética / Medicina Reproductiva Año: 2020 Tipo del documento: Artículo País de afiliación: S10815-020-01821-7

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Atención a la Salud / Pandemias / Preservación de la Fertilidad / Betacoronavirus / Neoplasias Tipo de estudio: Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Límite: Femenino / Humanos Idioma: Inglés Revista: J Assist Reprod Genet Asunto de la revista: Genética / Medicina Reproductiva Año: 2020 Tipo del documento: Artículo País de afiliación: S10815-020-01821-7